Sarvmangal Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -11.36%
(FY 2023)
- Profit -23.45%
(FY 2023)
- Ebitda
- Net Worth 3.19%
(FY 2023)
- Total Assets 1.45%
(FY 2023)
About Sarvmangal Life Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitya Batra and Puneet Batra serve as directors at the Company.
- CIN/LLPIN
U85100HR2020PTC086071
- Company No.
086071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Apr 2020
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarvmangal Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitya Batra  | Director | 14-Apr-2020 | Current |
| Puneet Batra | Director | 14-Apr-2020 | Current |
Financial Performance of Sarvmangal Life Science.
Sarvmangal Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.36% decrease. The company also saw a substantial fall in profitability, with a 23.45% decrease in profit. The company's net worth moved up by a moderate rise of 3.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sarvmangal Life Science?
Unlock access to Sarvmangal Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Suryashakti Vessels Private LimitedActive 27 years 5 monthsNitya Batra and Puneet Batra are mutual person
Surya Shakti Pressure Vessels LlpActive 3 years 6 monthsNitya Batra and Puneet Batra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarvmangal Life Science?
Sarvmangal Life Science has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarvmangal Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarvmangal Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
